June 26, 2018

AbbVie, Calibr partner to develop T-cell therapies for solid tumors

By admin

This collaboration broadens AbbVie’s oncology research to access advanced precision medicine technology to expand the development of potentially life-changing treatments for patients with cancer. Chimeric Antigen Receptor T-cell